Humacyte, Inc.·4

Sep 3, 4:23 PM ET

Niklason Laura E 4

4 · Humacyte, Inc. · Filed Sep 3, 2024

Insider Transaction Report

Form 4
Period: 2024-08-29
Niklason Laura E
DirectorPresident, CEO and Director
Transactions
  • Purchase

    Common Stock

    2024-08-29$6.54/sh+1,222$7,998242,054 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    510,161
  • Common Stock

    (indirect: By Trust)
    1,148,240
  • Common Stock

    (indirect: By LLC)
    3,677,262
Footnotes (1)
  • [F1]This purchase is matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, against a portion of the sale by Ayabudge LLC, an entity controlled by the Reporting Person's spouse, of 809,786 shares of the Issuer's common stock on May 31, 2024. The Reporting Person has paid the Issuer $3,391.05, representing the full amount of profit realized in connection with this purchase.

Documents

1 file
  • 4
    wk-form4_1725395025.xmlPrimary

    FORM 4